| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Renal Insufficiency, Chronic | 16 | 2019 | 2654 | 2.51 | Why? |
| Diabetic Nephropathies | 7 | 2018 | 315 | 1.92 | Why? |
| Urea | 2 | 2018 | 228 | 1.29 | Why? |
| Kidney | 15 | 2020 | 3648 | 1.22 | Why? |
| Dietary Proteins | 4 | 2018 | 112 | 1.06 | Why? |
| Adult Stem Cells | 2 | 2019 | 68 | 0.96 | Why? |
| Phosphorus, Dietary | 2 | 2018 | 4 | 0.96 | Why? |
| Sodium, Dietary | 3 | 2018 | 45 | 0.94 | Why? |
| Diet, Protein-Restricted | 3 | 2018 | 80 | 0.91 | Why? |
| Myofibroblasts | 2 | 2019 | 61 | 0.91 | Why? |
| Uremia | 2 | 2018 | 50 | 0.91 | Why? |
| Chemokine CXCL6 | 1 | 2019 | 4 | 0.82 | Why? |
| Salivary Proteins and Peptides | 1 | 2019 | 12 | 0.82 | Why? |
| Lipoproteins, HDL | 1 | 2021 | 154 | 0.79 | Why? |
| Ubiquitination | 2 | 2018 | 343 | 0.78 | Why? |
| Energy Intake | 2 | 2018 | 323 | 0.75 | Why? |
| Cortical Synchronization | 1 | 2018 | 3 | 0.74 | Why? |
| Alpha Rhythm | 1 | 2018 | 9 | 0.74 | Why? |
| Xenobiotics | 1 | 2018 | 37 | 0.73 | Why? |
| Pericytes | 2 | 2018 | 108 | 0.73 | Why? |
| Cell Transdifferentiation | 1 | 2018 | 47 | 0.73 | Why? |
| Renal Elimination | 1 | 2018 | 62 | 0.72 | Why? |
| Osteoclasts | 1 | 2018 | 67 | 0.70 | Why? |
| Bone Resorption | 1 | 2018 | 61 | 0.70 | Why? |
| Cresols | 1 | 2017 | 8 | 0.69 | Why? |
| Serum Amyloid A Protein | 1 | 2019 | 211 | 0.69 | Why? |
| Lysine | 1 | 2018 | 153 | 0.69 | Why? |
| eIF-2 Kinase | 1 | 2018 | 117 | 0.69 | Why? |
| Sulfuric Acid Esters | 1 | 2017 | 28 | 0.68 | Why? |
| Ubiquinone | 1 | 2017 | 91 | 0.65 | Why? |
| Mitochondrial Diseases | 1 | 2017 | 62 | 0.64 | Why? |
| Reperfusion Injury | 1 | 2018 | 178 | 0.63 | Why? |
| Gastrointestinal Microbiome | 3 | 2018 | 1961 | 0.62 | Why? |
| Ataxia | 1 | 2017 | 133 | 0.62 | Why? |
| Cell Differentiation | 3 | 2019 | 1338 | 0.60 | Why? |
| beta-Glucans | 1 | 2017 | 176 | 0.56 | Why? |
| Nephrotic Syndrome | 1 | 2017 | 146 | 0.56 | Why? |
| Complement Activation | 2 | 2018 | 949 | 0.55 | Why? |
| Autophagy | 3 | 2018 | 960 | 0.54 | Why? |
| Dietary Fiber | 3 | 2018 | 73 | 0.52 | Why? |
| Muscle Weakness | 1 | 2017 | 406 | 0.51 | Why? |
| Proteins | 2 | 2018 | 921 | 0.50 | Why? |
| Acute Kidney Injury | 8 | 2021 | 5762 | 0.47 | Why? |
| Housing | 1 | 2020 | 1146 | 0.47 | Why? |
| Intestines | 1 | 2018 | 817 | 0.46 | Why? |
| Genome-Wide Association Study | 3 | 2018 | 1648 | 0.44 | Why? |
| Kidney Diseases | 6 | 2021 | 1434 | 0.39 | Why? |
| Nephrology | 4 | 2021 | 546 | 0.39 | Why? |
| Urinary Tract | 3 | 2018 | 77 | 0.39 | Why? |
| Endothelial Cells | 2 | 2019 | 2048 | 0.39 | Why? |
| Sepsis | 4 | 2021 | 3517 | 0.38 | Why? |
| RNA | 1 | 2017 | 1278 | 0.38 | Why? |
| Dietary Supplements | 2 | 2018 | 2251 | 0.37 | Why? |
| Leukocytes, Mononuclear | 2 | 2018 | 2115 | 0.37 | Why? |
| Signal Transduction | 5 | 2019 | 7207 | 0.35 | Why? |
| Alzheimer Disease | 1 | 2018 | 1020 | 0.34 | Why? |
| Glomerulosclerosis, Focal Segmental | 3 | 2018 | 104 | 0.34 | Why? |
| Bacteria | 1 | 2018 | 1897 | 0.33 | Why? |
| Gene Expression Regulation | 3 | 2017 | 4020 | 0.33 | Why? |
| Hyperglycemia | 1 | 2018 | 1363 | 0.33 | Why? |
| Personnel, Hospital | 1 | 2020 | 2273 | 0.32 | Why? |
| MicroRNAs | 2 | 2017 | 1787 | 0.31 | Why? |
| Cognitive Dysfunction | 1 | 2018 | 1389 | 0.31 | Why? |
| Endothelium, Vascular | 1 | 2017 | 1751 | 0.29 | Why? |
| Diet | 4 | 2018 | 2052 | 0.28 | Why? |
| Cholesterol | 2 | 2021 | 660 | 0.28 | Why? |
| Tissue Inhibitor of Metalloproteinase-3 | 2 | 2013 | 3 | 0.27 | Why? |
| Kidney Glomerulus | 2 | 2018 | 144 | 0.27 | Why? |
| Glomerulonephritis, IGA | 3 | 2020 | 115 | 0.26 | Why? |
| Dysbiosis | 3 | 2018 | 685 | 0.26 | Why? |
| Chromatography, Liquid | 2 | 2017 | 640 | 0.25 | Why? |
| Stem Cells | 2 | 2019 | 595 | 0.24 | Why? |
| Urogenital Abnormalities | 2 | 2018 | 10 | 0.24 | Why? |
| Kidney Tubules | 3 | 2018 | 205 | 0.24 | Why? |
| Renal Dialysis | 5 | 2020 | 4358 | 0.24 | Why? |
| Cardiovascular Diseases | 2 | 2018 | 11497 | 0.24 | Why? |
| Mutation | 3 | 2017 | 12376 | 0.23 | Why? |
| Pre-Eclampsia | 2 | 2019 | 599 | 0.23 | Why? |
| Cells, Cultured | 5 | 2019 | 5835 | 0.22 | Why? |
| Glomerulonephritis | 3 | 2018 | 226 | 0.21 | Why? |
| Chromosome Deletion | 2 | 2018 | 62 | 0.21 | Why? |
| Proteinuria | 3 | 2019 | 474 | 0.21 | Why? |
| Tandem Mass Spectrometry | 2 | 2017 | 1031 | 0.21 | Why? |
| Focal Adhesions | 1 | 2019 | 10 | 0.21 | Why? |
| Elastomers | 1 | 2019 | 31 | 0.20 | Why? |
| Vesico-Ureteral Reflux | 1 | 2018 | 17 | 0.20 | Why? |
| Hemodynamics | 2 | 2018 | 1562 | 0.19 | Why? |
| Endothelin A Receptor Antagonists | 1 | 2018 | 10 | 0.19 | Why? |
| Exome | 2 | 2017 | 207 | 0.19 | Why? |
| Apoptosis | 3 | 2018 | 2335 | 0.19 | Why? |
| Potassium, Dietary | 1 | 2018 | 10 | 0.19 | Why? |
| Mechanical Phenomena | 1 | 2019 | 50 | 0.19 | Why? |
| Stevia | 1 | 2018 | 2 | 0.19 | Why? |
| Synbiotics | 1 | 2018 | 15 | 0.19 | Why? |
| Spiro Compounds | 1 | 2018 | 28 | 0.19 | Why? |
| Receptors, Phospholipase A2 | 1 | 2018 | 14 | 0.19 | Why? |
| Legionella pneumophila | 1 | 2020 | 143 | 0.19 | Why? |
| Myeloid Differentiation Factor 88 | 1 | 2019 | 109 | 0.19 | Why? |
| AC133 Antigen | 1 | 2018 | 19 | 0.19 | Why? |
| Regeneration | 2 | 2019 | 429 | 0.19 | Why? |
| Cooking | 1 | 2019 | 144 | 0.19 | Why? |
| DNA Copy Number Variations | 1 | 2018 | 84 | 0.19 | Why? |
| Diet, Sodium-Restricted | 1 | 2018 | 23 | 0.19 | Why? |
| Coculture Techniques | 1 | 2019 | 258 | 0.19 | Why? |
| Delta Rhythm | 1 | 2018 | 3 | 0.19 | Why? |
| Prebiotics | 1 | 2018 | 53 | 0.18 | Why? |
| Gene Expression | 3 | 2019 | 3332 | 0.18 | Why? |
| Pedigree | 2 | 2017 | 502 | 0.18 | Why? |
| Contraindications | 1 | 2018 | 96 | 0.18 | Why? |
| Nitrites | 1 | 2018 | 43 | 0.18 | Why? |
| Albuminuria | 2 | 2017 | 164 | 0.18 | Why? |
| Sus scrofa | 1 | 2019 | 205 | 0.18 | Why? |
| RANK Ligand | 1 | 2018 | 47 | 0.18 | Why? |
| Phosphatidylethanolamine Binding Protein | 1 | 2017 | 2 | 0.18 | Why? |
| Patient Compliance | 2 | 2018 | 1468 | 0.18 | Why? |
| Nitrates | 1 | 2018 | 98 | 0.18 | Why? |
| Urokinase-Type Plasminogen Activator | 1 | 2018 | 62 | 0.18 | Why? |
| Humans | 63 | 2021 | 930598 | 0.18 | Why? |
| Vitamin K 1 | 1 | 2017 | 26 | 0.18 | Why? |
| Aquaporin 2 | 1 | 2017 | 2 | 0.18 | Why? |
| Kidney Transplantation | 5 | 2018 | 5397 | 0.18 | Why? |
| Dietary Fats | 1 | 2018 | 96 | 0.17 | Why? |
| Aquaporin 5 | 1 | 2017 | 13 | 0.17 | Why? |
| Glomerular Filtration Rate | 3 | 2020 | 1262 | 0.17 | Why? |
| Glomerulonephritis, Membranous | 1 | 2018 | 71 | 0.17 | Why? |
| Angioedemas, Hereditary | 1 | 2018 | 55 | 0.17 | Why? |
| Coffee | 1 | 2018 | 79 | 0.17 | Why? |
| Anorexia | 1 | 2018 | 194 | 0.17 | Why? |
| DiGeorge Syndrome | 1 | 2017 | 15 | 0.17 | Why? |
| Alcohols | 1 | 2018 | 86 | 0.17 | Why? |
| Haploinsufficiency | 1 | 2017 | 28 | 0.17 | Why? |
| Fluorocarbons | 1 | 2018 | 102 | 0.17 | Why? |
| Complement System Proteins | 1 | 2021 | 380 | 0.17 | Why? |
| Inflammation | 4 | 2018 | 13255 | 0.17 | Why? |
| Gene Silencing | 1 | 2018 | 213 | 0.17 | Why? |
| Tuberous Sclerosis | 1 | 2017 | 63 | 0.17 | Why? |
| Epithelial Cells | 3 | 2018 | 3508 | 0.17 | Why? |
| DNA Mutational Analysis | 2 | 2017 | 581 | 0.17 | Why? |
| Apoptosis Regulatory Proteins | 1 | 2018 | 202 | 0.17 | Why? |
| Aneurysm, Ruptured | 1 | 2018 | 109 | 0.16 | Why? |
| Microtubule-Associated Proteins | 1 | 2018 | 187 | 0.16 | Why? |
| Complement C1 Inhibitor Protein | 1 | 2018 | 124 | 0.16 | Why? |
| Rest | 1 | 2018 | 188 | 0.16 | Why? |
| Urinalysis | 1 | 2018 | 218 | 0.16 | Why? |
| Tea | 1 | 2018 | 126 | 0.16 | Why? |
| Fatty Acids | 1 | 2018 | 238 | 0.16 | Why? |
| Lipid Metabolism | 1 | 2021 | 572 | 0.16 | Why? |
| Spectrometry, Mass, Electrospray Ionization | 1 | 2017 | 159 | 0.16 | Why? |
| Signal Processing, Computer-Assisted | 1 | 2018 | 193 | 0.15 | Why? |
| Preliminary Data | 1 | 2018 | 457 | 0.15 | Why? |
| Congenital Abnormalities | 1 | 2017 | 170 | 0.15 | Why? |
| Intra-Abdominal Fat | 1 | 2018 | 227 | 0.15 | Why? |
| Animals | 12 | 2019 | 78931 | 0.15 | Why? |
| Adrenomedullin | 1 | 2018 | 217 | 0.15 | Why? |
| Heart Failure | 1 | 2017 | 6638 | 0.15 | Why? |
| Fluorescent Antibody Technique | 1 | 2018 | 835 | 0.15 | Why? |
| Transforming Growth Factor beta | 1 | 2017 | 363 | 0.14 | Why? |
| Cell Death | 1 | 2017 | 536 | 0.14 | Why? |
| Nausea | 1 | 2018 | 457 | 0.14 | Why? |
| Epithelial-Mesenchymal Transition | 1 | 2017 | 242 | 0.14 | Why? |
| Charcot-Marie-Tooth Disease | 1 | 2014 | 22 | 0.14 | Why? |
| Microfilament Proteins | 1 | 2014 | 45 | 0.14 | Why? |
| Cross-Over Studies | 1 | 2018 | 867 | 0.14 | Why? |
| Posterior Leukoencephalopathy Syndrome | 1 | 2018 | 213 | 0.14 | Why? |
| Lipopolysaccharides | 1 | 2019 | 848 | 0.14 | Why? |
| Nerve Tissue Proteins | 1 | 2017 | 319 | 0.14 | Why? |
| Kidney Function Tests | 1 | 2017 | 520 | 0.14 | Why? |
| Endocrinology | 1 | 2017 | 252 | 0.14 | Why? |
| Disease Progression | 6 | 2020 | 13580 | 0.13 | Why? |
| Nuclear Proteins | 1 | 2017 | 321 | 0.13 | Why? |
| Nutrition Assessment | 1 | 2018 | 527 | 0.13 | Why? |
| Biopsy | 6 | 2019 | 2811 | 0.13 | Why? |
| Female | 33 | 2020 | 380317 | 0.13 | Why? |
| Immunohistochemistry | 2 | 2018 | 2275 | 0.13 | Why? |
| Healthy Lifestyle | 1 | 2018 | 447 | 0.13 | Why? |
| Probiotics | 2 | 2018 | 694 | 0.13 | Why? |
| Italy | 12 | 2021 | 38444 | 0.13 | Why? |
| Hyponatremia | 1 | 2017 | 371 | 0.13 | Why? |
| Angiotensin II Type 1 Receptor Blockers | 1 | 2018 | 520 | 0.13 | Why? |
| Male | 30 | 2020 | 367725 | 0.13 | Why? |
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 502 | 0.12 | Why? |
| Intracranial Aneurysm | 1 | 2018 | 504 | 0.12 | Why? |
| Curcumin | 1 | 2018 | 396 | 0.12 | Why? |
| Wakefulness | 1 | 2018 | 598 | 0.12 | Why? |
| Insulin Resistance | 1 | 2018 | 669 | 0.12 | Why? |
| Neuropsychological Tests | 1 | 2018 | 954 | 0.12 | Why? |
| Neoplasm Proteins | 1 | 2017 | 501 | 0.12 | Why? |
| Receptors, Opioid, mu | 1 | 2011 | 23 | 0.12 | Why? |
| Swine | 2 | 2018 | 3352 | 0.12 | Why? |
| Medical Oncology | 2 | 2019 | 3826 | 0.12 | Why? |
| Overweight | 1 | 2018 | 916 | 0.12 | Why? |
| Forkhead Transcription Factors | 1 | 2013 | 231 | 0.11 | Why? |
| Living Donors | 1 | 2017 | 652 | 0.11 | Why? |
| Nanostructures | 1 | 2019 | 700 | 0.11 | Why? |
| STAT1 Transcription Factor | 1 | 2013 | 313 | 0.11 | Why? |
| Healthy Volunteers | 1 | 2017 | 1444 | 0.11 | Why? |
| Diabetes Mellitus, Experimental | 1 | 2013 | 192 | 0.11 | Why? |
| Kidney Failure, Chronic | 2 | 2019 | 3222 | 0.10 | Why? |
| Electroencephalography | 1 | 2018 | 1242 | 0.10 | Why? |
| Carcinoma, Renal Cell | 1 | 2017 | 545 | 0.10 | Why? |
| Cardiovascular System | 1 | 2018 | 750 | 0.10 | Why? |
| NF-kappa B | 1 | 2017 | 1301 | 0.10 | Why? |
| Rituximab | 1 | 2018 | 1096 | 0.10 | Why? |
| Geriatric Assessment | 1 | 2019 | 1372 | 0.10 | Why? |
| Molecular Targeted Therapy | 1 | 2019 | 1579 | 0.10 | Why? |
| Membrane Proteins | 2 | 2017 | 1733 | 0.10 | Why? |
| Sulfonamides | 1 | 2018 | 1294 | 0.10 | Why? |
| Mice, Inbred C57BL | 2 | 2018 | 5542 | 0.10 | Why? |
| Consensus | 3 | 2019 | 6345 | 0.09 | Why? |
| Nutritional Status | 1 | 2019 | 1403 | 0.09 | Why? |
| Renal Replacement Therapy | 1 | 2018 | 1530 | 0.09 | Why? |
| Malnutrition | 1 | 2018 | 932 | 0.09 | Why? |
| Kidney Neoplasms | 1 | 2017 | 832 | 0.09 | Why? |
| Societies, Medical | 3 | 2021 | 6907 | 0.09 | Why? |
| Needs Assessment | 1 | 2019 | 2352 | 0.09 | Why? |
| Patient Education as Topic | 1 | 2018 | 1476 | 0.09 | Why? |
| Heart | 1 | 2018 | 1791 | 0.09 | Why? |
| Tissue Donors | 1 | 2017 | 1679 | 0.09 | Why? |
| Adult | 20 | 2020 | 244371 | 0.09 | Why? |
| Multiple Organ Failure | 1 | 2018 | 1724 | 0.09 | Why? |
| Pain, Postoperative | 1 | 2011 | 289 | 0.09 | Why? |
| Patient Care Team | 2 | 2019 | 3556 | 0.08 | Why? |
| Mice | 5 | 2018 | 21357 | 0.08 | Why? |
| Autoantibodies | 1 | 2018 | 2094 | 0.08 | Why? |
| Middle Aged | 19 | 2020 | 270681 | 0.08 | Why? |
| Aged | 15 | 2020 | 215776 | 0.08 | Why? |
| Case-Control Studies | 4 | 2018 | 17671 | 0.08 | Why? |
| Stroke Volume | 1 | 2017 | 2153 | 0.08 | Why? |
| Enzyme-Linked Immunosorbent Assay | 3 | 2018 | 7868 | 0.08 | Why? |
| Protein Kinases | 1 | 2007 | 93 | 0.08 | Why? |
| Inflammation Mediators | 1 | 2018 | 2654 | 0.08 | Why? |
| Zebrafish | 2 | 2017 | 181 | 0.08 | Why? |
| Oxidative Stress | 1 | 2017 | 2050 | 0.08 | Why? |
| Placenta | 1 | 2017 | 1531 | 0.08 | Why? |
| Sarcoma, Kaposi | 1 | 2007 | 97 | 0.08 | Why? |
| Diabetes Mellitus, Type 2 | 2 | 2017 | 6166 | 0.07 | Why? |
| ROC Curve | 1 | 2018 | 6024 | 0.07 | Why? |
| Hematuria | 2 | 2018 | 284 | 0.07 | Why? |
| Sirolimus | 1 | 2007 | 240 | 0.07 | Why? |
| Prospective Studies | 4 | 2018 | 43301 | 0.07 | Why? |
| Mesangial Cells | 2 | 2013 | 5 | 0.07 | Why? |
| Risk Factors | 6 | 2020 | 71621 | 0.07 | Why? |
| Health Services Needs and Demand | 1 | 2019 | 3419 | 0.07 | Why? |
| Heterozygote | 2 | 2017 | 249 | 0.06 | Why? |
| Immunosuppressive Agents | 2 | 2021 | 6331 | 0.06 | Why? |
| Biomarkers | 6 | 2018 | 23361 | 0.06 | Why? |
| Echocardiography | 1 | 2017 | 3661 | 0.06 | Why? |
| Evidence-Based Medicine | 1 | 2016 | 3228 | 0.06 | Why? |
| Virus Internalization | 1 | 2021 | 7921 | 0.06 | Why? |
| Follow-Up Studies | 2 | 2020 | 17020 | 0.06 | Why? |
| Computer Simulation | 1 | 2017 | 4982 | 0.06 | Why? |
| Immunologic Factors | 1 | 2018 | 4206 | 0.06 | Why? |
| Analgesics, Opioid | 1 | 2011 | 1070 | 0.06 | Why? |
| Creatinine | 2 | 2018 | 1443 | 0.05 | Why? |
| Epidermal Growth Factor | 1 | 2000 | 44 | 0.05 | Why? |
| TOR Serine-Threonine Kinases | 2 | 2018 | 385 | 0.05 | Why? |
| Brain | 1 | 2018 | 5133 | 0.05 | Why? |
| Prognosis | 4 | 2020 | 32490 | 0.05 | Why? |
| Cohort Studies | 6 | 2020 | 36005 | 0.05 | Why? |
| Dimethylpolysiloxanes | 1 | 2019 | 46 | 0.05 | Why? |
| Prevalence | 5 | 2021 | 25773 | 0.05 | Why? |
| Nylons | 1 | 2019 | 34 | 0.05 | Why? |
| Ureteral Obstruction | 1 | 2000 | 61 | 0.05 | Why? |
| Phosphorylation | 2 | 2017 | 1060 | 0.05 | Why? |
| Phenotype | 3 | 2017 | 4037 | 0.05 | Why? |
| Young Adult | 7 | 2018 | 93724 | 0.05 | Why? |
| Forms and Records Control | 1 | 2018 | 32 | 0.05 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2018 | 10649 | 0.05 | Why? |
| Geriatricians | 1 | 2019 | 71 | 0.05 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 9335 | 0.05 | Why? |
| Fractals | 1 | 2018 | 25 | 0.05 | Why? |
| Biomechanical Phenomena | 1 | 2019 | 291 | 0.05 | Why? |
| Cross Infection | 1 | 2020 | 8675 | 0.04 | Why? |
| Heredity | 1 | 2017 | 37 | 0.04 | Why? |
| Antimetabolites | 1 | 2018 | 106 | 0.04 | Why? |
| Diet, Vegan | 1 | 2017 | 4 | 0.04 | Why? |
| Water Microbiology | 1 | 2020 | 248 | 0.04 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2011 | 3607 | 0.04 | Why? |
| Alkalies | 1 | 2017 | 3 | 0.04 | Why? |
| Nephritis | 1 | 2018 | 39 | 0.04 | Why? |
| Mice, Knockout | 2 | 2013 | 1815 | 0.04 | Why? |
| Chemokine CCL2 | 1 | 2000 | 389 | 0.04 | Why? |
| Chromosomes, Human, Pair 22 | 1 | 2017 | 10 | 0.04 | Why? |
| Jurkat Cells | 1 | 2018 | 273 | 0.04 | Why? |
| Genetic Heterogeneity | 1 | 2017 | 77 | 0.04 | Why? |
| Host-Pathogen Interactions | 1 | 2018 | 11041 | 0.04 | Why? |
| Tissue Array Analysis | 1 | 2017 | 75 | 0.04 | Why? |
| Surface Properties | 1 | 2019 | 448 | 0.04 | Why? |
| Diet, Vegetarian | 1 | 2017 | 31 | 0.04 | Why? |
| Hemopexin | 1 | 2016 | 5 | 0.04 | Why? |
| Water Supply | 1 | 2020 | 294 | 0.04 | Why? |
| Waist Circumference | 1 | 2018 | 199 | 0.04 | Why? |
| Systemic Vasculitis | 1 | 2018 | 74 | 0.04 | Why? |
| Adolescent | 9 | 2020 | 86841 | 0.04 | Why? |
| Nephrologists | 1 | 2019 | 117 | 0.04 | Why? |
| Pathogen-Associated Molecular Pattern Molecules | 1 | 2017 | 108 | 0.04 | Why? |
| Acid-Base Equilibrium | 1 | 2017 | 53 | 0.04 | Why? |
| Electrophoresis, Gel, Two-Dimensional | 1 | 2016 | 40 | 0.04 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 11367 | 0.04 | Why? |
| Obesity | 1 | 2018 | 7388 | 0.04 | Why? |
| Sorption Detoxification | 1 | 2016 | 23 | 0.04 | Why? |
| alpha-2-HS-Glycoprotein | 1 | 2016 | 25 | 0.04 | Why? |
| Cytochromes c | 1 | 2016 | 44 | 0.04 | Why? |
| Calcineurin Inhibitors | 1 | 2018 | 218 | 0.04 | Why? |
| Biopsy, Needle | 1 | 2018 | 303 | 0.04 | Why? |
| Homozygote | 1 | 2017 | 230 | 0.04 | Why? |
| Orosomucoid | 1 | 2016 | 60 | 0.04 | Why? |
| Electrophoresis, Polyacrylamide Gel | 1 | 2016 | 238 | 0.04 | Why? |
| Human Umbilical Vein Endothelial Cells | 1 | 2018 | 286 | 0.04 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.04 | Why? |
| Acute-Phase Reaction | 1 | 2016 | 116 | 0.04 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Alarmins | 1 | 2017 | 180 | 0.04 | Why? |
| Predictive Value of Tests | 3 | 2019 | 9537 | 0.04 | Why? |
| Haptoglobins | 1 | 2016 | 117 | 0.04 | Why? |
| Medical Records | 1 | 2018 | 513 | 0.04 | Why? |
| Urine | 1 | 2018 | 469 | 0.04 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.04 | Why? |
| Age of Onset | 1 | 2017 | 557 | 0.04 | Why? |
| Water | 1 | 2020 | 765 | 0.04 | Why? |
| Amniotic Fluid | 1 | 2017 | 249 | 0.04 | Why? |
| Practice Guidelines as Topic | 1 | 2020 | 15421 | 0.04 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.04 | Why? |
| Automation, Laboratory | 1 | 2018 | 536 | 0.04 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.04 | Why? |
| Quality Control | 1 | 2018 | 628 | 0.04 | Why? |
| Child | 7 | 2020 | 70012 | 0.04 | Why? |
| Cellular Senescence | 1 | 2018 | 326 | 0.03 | Why? |
| Graft Survival | 1 | 2017 | 587 | 0.03 | Why? |
| Retrospective Studies | 4 | 2018 | 105322 | 0.03 | Why? |
| Advisory Committees | 1 | 2021 | 1418 | 0.03 | Why? |
| Forkhead Box Protein O1 | 1 | 2013 | 31 | 0.03 | Why? |
| Models, Animal | 1 | 2017 | 788 | 0.03 | Why? |
| Health Personnel | 2 | 2021 | 29646 | 0.03 | Why? |
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2017 | 449 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2020 | 2324 | 0.03 | Why? |
| Microvessels | 1 | 2017 | 490 | 0.03 | Why? |
| Fetal Blood | 1 | 2017 | 573 | 0.03 | Why? |
| Skin Neoplasms | 1 | 2007 | 1679 | 0.03 | Why? |
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2017 | 624 | 0.03 | Why? |
| RNA, Long Noncoding | 1 | 2017 | 408 | 0.03 | Why? |
| Escherichia coli | 1 | 2020 | 1547 | 0.03 | Why? |
| Sufentanil | 1 | 2011 | 8 | 0.03 | Why? |
| Proteolysis | 1 | 2016 | 751 | 0.03 | Why? |
| Disease-Free Survival | 1 | 2017 | 1654 | 0.03 | Why? |
| Cattle | 1 | 2016 | 1336 | 0.03 | Why? |
| Reproducibility of Results | 2 | 2018 | 11304 | 0.03 | Why? |
| Gene Expression Profiling | 2 | 2013 | 3788 | 0.03 | Why? |
| Sequence Homology, Amino Acid | 1 | 2014 | 945 | 0.03 | Why? |
| Alleles | 1 | 2017 | 1557 | 0.03 | Why? |
| Tramadol | 1 | 2011 | 40 | 0.03 | Why? |
| Primary Cell Culture | 1 | 2013 | 501 | 0.03 | Why? |
| Observational Studies as Topic | 1 | 2019 | 1887 | 0.03 | Why? |
| Lipids | 1 | 2018 | 1079 | 0.03 | Why? |
| Pituitary-Adrenal System | 1 | 2011 | 135 | 0.03 | Why? |
| Severity of Illness Index | 2 | 2017 | 48226 | 0.03 | Why? |
| Antineoplastic Agents | 1 | 2007 | 3550 | 0.03 | Why? |
| Frail Elderly | 1 | 2020 | 1427 | 0.03 | Why? |
| Cell Proliferation | 1 | 2018 | 1973 | 0.03 | Why? |
| Filtration | 1 | 2016 | 820 | 0.03 | Why? |
| Neoplasms | 1 | 2019 | 17251 | 0.03 | Why? |
| Hypothalamo-Hypophyseal System | 1 | 2011 | 187 | 0.03 | Why? |
| Transfection | 1 | 2013 | 864 | 0.03 | Why? |
| DNA Primers | 1 | 2014 | 1170 | 0.02 | Why? |
| RNA Interference | 1 | 2013 | 534 | 0.02 | Why? |
| Pregnancy | 3 | 2019 | 23879 | 0.02 | Why? |
| Diagnostic Imaging | 1 | 2018 | 1044 | 0.02 | Why? |
| Dose-Response Relationship, Drug | 1 | 2018 | 3776 | 0.02 | Why? |
| Time Factors | 3 | 2019 | 31397 | 0.02 | Why? |
| Molecular Sequence Data | 1 | 2014 | 3198 | 0.02 | Why? |
| Sensitivity and Specificity | 2 | 2021 | 22971 | 0.02 | Why? |
| Pain Measurement | 1 | 2011 | 533 | 0.02 | Why? |
| Analysis of Variance | 1 | 2011 | 950 | 0.02 | Why? |
| Biomarkers, Tumor | 1 | 2017 | 1314 | 0.02 | Why? |
| Sequence Analysis, DNA | 1 | 2017 | 2830 | 0.02 | Why? |
| Hospitals, University | 1 | 2020 | 4173 | 0.02 | Why? |
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2007 | 15 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2017 | 4260 | 0.02 | Why? |
| Infant, Newborn | 3 | 2017 | 23105 | 0.02 | Why? |
| Double-Blind Method | 1 | 2018 | 5988 | 0.02 | Why? |
| Age Factors | 2 | 2019 | 21039 | 0.02 | Why? |
| Hospitals, Pediatric | 1 | 2018 | 1792 | 0.02 | Why? |
| Blood Pressure | 1 | 2018 | 2198 | 0.02 | Why? |
| Gene Frequency | 1 | 2011 | 1210 | 0.02 | Why? |
| Infant | 3 | 2018 | 30274 | 0.02 | Why? |
| Liver Cirrhosis | 1 | 2017 | 1810 | 0.02 | Why? |
| Neurosurgical Procedures | 1 | 2017 | 1738 | 0.02 | Why? |
| Neurology | 1 | 2017 | 1613 | 0.02 | Why? |
| Genotype | 1 | 2017 | 4697 | 0.02 | Why? |
| Acute Disease | 1 | 2018 | 6029 | 0.02 | Why? |
| Body Mass Index | 1 | 2018 | 4306 | 0.02 | Why? |
| Pilot Projects | 1 | 2017 | 5182 | 0.02 | Why? |
| Incidence | 2 | 2018 | 25622 | 0.02 | Why? |
| Transcriptome | 1 | 2018 | 3466 | 0.02 | Why? |
| Software | 1 | 2016 | 2501 | 0.02 | Why? |
| Proto-Oncogene Proteins c-akt | 1 | 2007 | 372 | 0.02 | Why? |
| Blood Glucose | 1 | 2018 | 3642 | 0.02 | Why? |
| Genetic Predisposition to Disease | 1 | 2018 | 4027 | 0.02 | Why? |
| Aged, 80 and over | 3 | 2019 | 88759 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2021 | 9091 | 0.02 | Why? |
| Cluster Analysis | 1 | 2011 | 3001 | 0.02 | Why? |
| Amino Acid Sequence | 1 | 2014 | 6049 | 0.02 | Why? |
| Referral and Consultation | 1 | 2019 | 4816 | 0.01 | Why? |
| Renin-Angiotensin System | 1 | 2018 | 3661 | 0.01 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.01 | Why? |
| Radioisotope Renography | 1 | 2000 | 2 | 0.01 | Why? |
| Monocytes | 2 | 2007 | 2978 | 0.01 | Why? |
| Computational Biology | 1 | 2016 | 4514 | 0.01 | Why? |
| Hydrocortisone | 1 | 2011 | 1790 | 0.01 | Why? |
| Cesarean Section | 1 | 2011 | 2089 | 0.01 | Why? |
| Hospitals | 1 | 2021 | 11793 | 0.01 | Why? |
| Specimen Handling | 1 | 2018 | 6190 | 0.01 | Why? |
| Adrenal Cortex Hormones | 1 | 2018 | 6537 | 0.01 | Why? |
| Sex Factors | 1 | 2018 | 11014 | 0.01 | Why? |
| Cross-Sectional Studies | 2 | 2018 | 53120 | 0.01 | Why? |
| Europe | 1 | 2017 | 12702 | 0.01 | Why? |
| Tertiary Care Centers | 1 | 2018 | 8248 | 0.01 | Why? |
| Antigens, Differentiation, Myelomonocytic | 1 | 2000 | 198 | 0.01 | Why? |
| Polymerase Chain Reaction | 1 | 2014 | 6740 | 0.01 | Why? |
| In Situ Hybridization | 1 | 2000 | 390 | 0.01 | Why? |
| Child, Preschool | 2 | 2018 | 36283 | 0.01 | Why? |
| Cell Line | 1 | 2013 | 12040 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.01 | Why? |
| Hypertension | 1 | 2018 | 8895 | 0.01 | Why? |
| Public Health | 1 | 2021 | 16359 | 0.01 | Why? |
| Antigens, CD | 1 | 2000 | 984 | 0.01 | Why? |
| China | 1 | 2020 | 50654 | 0.01 | Why? |
| Elective Surgical Procedures | 1 | 2011 | 5338 | 0.01 | Why? |
| Treatment Outcome | 2 | 2011 | 51732 | 0.01 | Why? |
| Patient Selection | 1 | 2007 | 4560 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.01 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.01 | Why? |
| RNA, Messenger | 1 | 2000 | 5131 | 0.00 | Why? |